PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Physiology, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.\', \'Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea; Infectious Disease Research Center, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.\', \'Stem Cell Research Institute, T&R Biofab Co. Ltd, Siheung, Republic of Korea.\', \'Infectious Disease Research Center, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.\', \'School of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology, Pohang, Republic of Korea.\', \'Division of Cardiology, Department of Internal Medicine, Seoul St. Mary\'s Hospital, Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, Republic of Korea.\', \'Department of Chemistry, City University of Hong Kong, Hong Kong SAR, China.\', \'Stem Cell Research Institute, T&R Biofab Co. Ltd, Siheung, Republic of Korea; Department of Medicine, Konkuk University School of Medicine, Seoul, Republic of Korea. Electronic address: sunghwanmoon@tnrbiofab.com.\', \'Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, China. Electronic address: kiwonban@cityu.edu.hk.\', \'Department of Infectious Diseases and Public Health, City University of Hong Kong, Hong Kong SAR, China. Electronic address: yunygo@cityu.edu.hk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0166-3542(20)30369-710.1016/j.antiviral.2020.104955
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 33091434
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all